These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Errors and Misinterpretations in Imaging of Chronic Liver Diseases. Morshid A; Szklaruk J; Yacoub JH; Elsayes KM Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):419-436. PubMed ID: 34243927 [TBL] [Abstract][Full Text] [Related]
84. Patient-Friendly Summary of the ACR Appropriateness Criteria: Chronic Liver Disease. Budis E; Uyeda JW J Am Coll Radiol; 2020 Nov; 17(11):e55. PubMed ID: 33153545 [No Abstract] [Full Text] [Related]
85. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Jin L; Li X Liver Int; 2021 Jan; 41(1):223. PubMed ID: 33025693 [No Abstract] [Full Text] [Related]
86. Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease. Khanna G; Alazraki AL Radiology; 2022 Sep; 304(3):670-671. PubMed ID: 35608449 [No Abstract] [Full Text] [Related]
87. Proceedings of the Contrast Media Research Symposium. Capri, Italy. October 14-18, 2001. Acad Radiol; 2002 Aug; 9 Suppl 2():S275-546. PubMed ID: 12580169 [No Abstract] [Full Text] [Related]
89. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Agostini A; Kircher MF; Do RK; Borgheresi A; Monti S; Giovagnoni A; Mannelli L Semin Roentgenol; 2016 Oct; 51(4):317-333. PubMed ID: 27743568 [No Abstract] [Full Text] [Related]
90. Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective. Borgheresi A; De Muzio F; Agostini A; Ottaviani L; Bruno A; Granata V; Fusco R; Danti G; Flammia F; Grassi R; Grassi F; Bruno F; Palumbo P; Barile A; Miele V; Giovagnoni A J Clin Med; 2022 May; 11(9):. PubMed ID: 35566723 [TBL] [Abstract][Full Text] [Related]
91. Masses in right side of the heart: spectrum of imaging findings. Pradella S; Grazzini G; Letteriello M; De Amicis C; Grassi R; Maggialetti N; Carbone M; Palumbo P; Carotti M; Di Cesare E; Giovagnoni A; Cozzi D; Miele V Acta Biomed; 2020 Jul; 91(8-S):60-70. PubMed ID: 32945280 [TBL] [Abstract][Full Text] [Related]
95. The role of imaging in surgical planning for liver resection: what the radiologist need to know. Agostini A; Borgheresi A; Floridi C; Carotti M; Grazzini G; Pagnini F; Guerrini S; Palumbo P; Pradella S; Carrafiello G; Vivarelli M; Giovagnoni A Acta Biomed; 2020 Jul; 91(8-S):18-26. PubMed ID: 32945275 [TBL] [Abstract][Full Text] [Related]
97. Diagnostic and interventional radiology: an update. Giovagnoni A; De Filippo M; Barile A Acta Biomed; 2020 Jul; 91(8-S):5-8. PubMed ID: 32945273 [TBL] [Abstract][Full Text] [Related]
98. State of the art in magnetic resonance imaging of hepatocellular carcinoma. Horvat N; Monti S; Oliveira BC; Rocha CCT; Giancipoli RG; Mannelli L Radiol Oncol; 2018 Nov; 52(4):353-364. PubMed ID: 30511939 [TBL] [Abstract][Full Text] [Related]
99. Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials. Agostini A; Kircher MF; Do R; Borgheresi A; Monti S; Giovagnoni A; Mannelli L Semin Roentgenol; 2016 Oct; 51(4):308-316. PubMed ID: 27743567 [No Abstract] [Full Text] [Related]
100. Use of magnetic resonance imaging contrast agents in the liver and biliary tract. Lebedis C; Luna A; Soto JA Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]